A detailed history of Black Rock Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,764,881 shares of EYPT stock, worth $39.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,764,881
Previous 2,787,359 35.07%
Holding current value
$39.5 Million
Previous $57.6 Million 43.15%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$8.16 - $22.89 $7.98 Million - $22.4 Million
977,522 Added 35.07%
3,764,881 $32.8 Million
Q1 2024

May 10, 2024

BUY
$19.93 - $29.71 $12.3 Million - $18.4 Million
618,053 Added 28.49%
2,787,359 $57.6 Million
Q4 2023

Feb 13, 2024

BUY
$5.71 - $24.13 $1.94 Million - $8.2 Million
339,856 Added 18.58%
2,169,306 $50.1 Million
Q3 2023

Nov 13, 2023

BUY
$7.99 - $15.36 $613,456 - $1.18 Million
76,778 Added 4.38%
1,829,450 $14.6 Million
Q2 2023

Aug 11, 2023

BUY
$3.03 - $9.0 $695,697 - $2.07 Million
229,603 Added 15.08%
1,752,672 $15.2 Million
Q1 2023

May 12, 2023

SELL
$2.28 - $5.04 $354,298 - $783,185
-155,394 Reduced 9.26%
1,523,069 $4.48 Million
Q4 2022

Feb 13, 2023

BUY
$2.37 - $7.2 $65,018 - $197,524
27,434 Added 1.66%
1,678,463 $5.87 Million
Q3 2022

Nov 14, 2022

BUY
$6.96 - $11.12 $572,578 - $914,809
82,267 Added 5.24%
1,651,029 $13.1 Million
Q2 2022

Aug 12, 2022

BUY
$7.25 - $12.71 $308,915 - $541,560
42,609 Added 2.79%
1,568,762 $12.3 Million
Q1 2022

May 12, 2022

BUY
$8.67 - $14.11 $741,475 - $1.21 Million
85,522 Added 5.94%
1,526,153 $18.5 Million
Q4 2021

Feb 10, 2022

BUY
$10.18 - $18.4 $2.54 Million - $4.6 Million
249,998 Added 21.0%
1,440,631 $17.6 Million
Q3 2021

Nov 09, 2021

BUY
$7.51 - $11.72 $457,276 - $713,619
60,889 Added 5.39%
1,190,633 $12.4 Million
Q2 2021

Aug 11, 2021

BUY
$8.69 - $11.08 $9.82 Million - $12.5 Million
1,129,744 New
1,129,744 $10.2 Million

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $357M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.